Global Molecular Diagnostics Industry POC 2021-2028 with analysis from bioMérieux, Roche, Danaher, Enzo Biochem, Abbott and other key players

DUBLIN, January 13, 2022 / PRNewswire / – The “Point-of-Care Molecular Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis” report has been added to ResearchAndMarkets.com offer.

Research and Markets logo

The global point-of-care molecular diagnostics market is expected to reach US $ 5,381.18 million by 2028 onwards US $ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.

The growth of the market is mainly attributed to the increasing demand for specific viral detection methods which consume less time for rapid infection control and the increasing incidence of infectious diseases. Moreover, increasing R&D and innovation in molecular point-of-care diagnostics is expected to drive the market growth during the forecast period. However, price pressures from reduced reimbursements are hampering market growth.

The COVID-19 pandemic has had a significant impact on the point-of-care molecular diagnostics market. Amid the pandemic, increased demand for diagnostic kits for the rapid detection of COVID-19 has spurred the adoption of point-of-care testing across the world. The growing number of COVID-19 cases and increasing pressure on various governments around the world to improve patient management has driven demand for rapid antigen test kits that can be used effectively in healthcare settings.

On the basis of products and services, the point-of-care molecular diagnostics market is segmented into tests and kits, instruments, services and software. The tests and kits segment is leading the market and is expected to register the highest CAGR during the forecast period.

Based on technology, the market is segmented into PCR, Isothermal Nucleic Acid Amplification (INAAT) technology, and other technologies. PCR segment dominates the market, while isothermal nucleic acid amplification technology (INAAT) segment is expected to register the highest CAGR during the forecast period.

By Application, the point-of-care molecular diagnostics market is segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. The infectious disease segment holds the largest share of the market. However, the oncology segment is expected to register the highest CAGR in the market during the forecast period.

By end user, the market is segmented into hospitals and clinics, diagnostic laboratories, research institutes and academics, etc. The diagnostic labs segment dominates the market and is expected to register the highest CAGR in the market during the forecast period.

Profiled companies

  • bioMérieux SA

  • F. Hoffmann-La Roche Ltée.

  • Danaher Company

  • Enzo Biochem, Inc.

  • Abbott

  • Binx Health, Inc.

  • Meridian BioScience, Inc.

  • Biocartis

  • Quidel Corporation

  • Bio-Rad Laboratories, Inc.

Reasons to buy

  • Gain and reduce the time required to perform entry-level research by identifying the growth, size, leading players and segments of the Point-of-Care Molecular Diagnostics market.

  • Highlights key business priorities to help companies realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global Point-of-Service Molecular Diagnostics Market, thereby enabling value chain players to develop effective long-term strategies.

  • Develop / modify business expansion plans using a substantial growth offering in developed and emerging markets.

  • Take an in-depth look at the global market trends and outlook associated with the factors driving the market, as well as those hindering it.

  • Improve the decision-making process by understanding the strategies that underpin security interests with respect to customer products, segmentation, pricing, and distribution.

For more information on this report, visit https://www.researchandmarkets.com/r/d7ji63

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

Cision

Cision

View original content: https://www.prnewswire.com/news-releases/global-poc-molecular-diagnostics-industry-2021-2028-featuring-analysis-of-biomerieux-roche-danaher-enzo-biochem-abbott – and-other-key-players-301460375.html

SOURCE Research and Markets


Source link

Comments are closed.